Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Currently there is no clear guidance for the treatment of moderate risk of pulmonary
embolism. The aim of the study is to compare two different therapeutic modalities - standard
anticoagulation versus thrombolytic treatment followed by anticoagulation in standard regimen
as stated in the pulmonary embolism guidelines.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Ostrava
Collaborators:
Municipal Hospital Ostrava Fifejdy Silesian Hospital Opava